Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer

The most common oncogenic driver in non-small-cell lung cancer (NSCLC) is the epidermal growth factor receptor (EGFR) gene mutations that occur more frequently among Asians (30%–50%) as opposed to Caucasians (10%–15%). Lung cancer is one of the most prevalent cancers in India, with a reported adenoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Batra, Ullas, Biswas, Bivas, Prabhash, Kumar, Krishna, M. Vamshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277533/
https://www.ncbi.nlm.nih.gov/pubmed/37321664
http://dx.doi.org/10.1136/bmjresp-2022-001492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277533/
https://www.ncbi.nlm.nih.gov/pubmed/37321664
http://dx.doi.org/10.1136/bmjresp-2022-001492

Ejemplares similares